In addition to its association with hepatitis B and liver cancer, the cGAS–STING signaling pathway has been shown to be activated in alcoholic liver disease (ALD), nonalcoholic fatty liver disease (NAFLD), and liver fibrosis. Here, STING1 is linked to Hepatic fibrosis.